UBS Group’s Medicines Co MDCO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
-1,277,342
| Closed | -$108M | – | 8868 |
|
|
2019
Q4 | $108M | Buy |
1,277,342
+754,143
| +144% | +$50.3M | 0.04% | 430 |
|
|
2019
Q3 | $26.2M | Buy |
523,199
+301,105
| +136% | +$12M | 0.01% | 1058 |
|
|
2019
Q2 | $8.1M | Sell |
222,094
-285,428
| -56% | -$9.32M | ﹤0.01% | 1927 |
|
|
2019
Q1 | $14.2M | Buy |
507,522
+93,855
| +23% | +$2.21M | 0.01% | 1399 |
|
|
2018
Q4 | $7.92M | Buy |
413,667
+348,310
| +533% | +$8.1M | ﹤0.01% | 1768 |
|
|
2018
Q3 | $1.95M | Buy |
65,357
+17,490
| +37% | +$659K | ﹤0.01% | 3242 |
|
|
2018
Q2 | $1.76M | Buy |
47,867
+2,225
| +5% | +$72.3K | ﹤0.01% | 3283 |
|
|
2018
Q1 | $1.5M | Buy |
45,642
+4,059
| +10% | +$127K | ﹤0.01% | 3362 |
|
|
2017
Q4 | $1.14M | Sell |
41,583
-13,677
| -25% | -$421K | ﹤0.01% | 3682 |
|
|
2017
Q3 | $2.05M | Buy |
55,260
+53
| +0.1% | +$1.95K | ﹤0.01% | 3111 |
|
|
2017
Q2 | $2.1M | Buy |
55,207
+6,631
| +14% | +$295K | ﹤0.01% | 2971 |
|
|
2017
Q1 | $2.38M | Buy |
48,576
+35,012
| +258% | +$1.6M | ﹤0.01% | 2784 |
|
|
2016
Q4 | $461K | Sell |
13,564
-126,168
| -90% | -$4.47M | ﹤0.01% | 4184 |
|
|
2016
Q3 | $5.27M | Buy |
139,732
+124,214
| +800% | +$4.68M | ﹤0.01% | 1972 |
|
|
2016
Q2 | $522K | Sell |
15,518
-616
| -4% | -$21.7K | ﹤0.01% | 3852 |
|
|
2016
Q1 | $512K | Buy |
16,134
+8,494
| +111% | +$277K | ﹤0.01% | 3762 |
|
|
2015
Q4 | $285K | Buy |
7,640
+103
| +1% | +$3.89K | ﹤0.01% | 4393 |
|
|
2015
Q3 | $286K | Buy |
7,537
+2,465
| +49% | +$86.5K | ﹤0.01% | 4355 |
|
|
2015
Q2 | $145K | Sell |
5,072
-366
| -7% | -$10.2K | ﹤0.01% | 5125 |
|
|
2015
Q1 | $152K | Buy |
5,438
+471
| +9% | +$13.2K | ﹤0.01% | 5098 |
|
|
2014
Q4 | $138K | Buy |
+4,967
| New | +$123K | ﹤0.01% | 5377 |
|
Other funds holding MDCO
UBS Group's MDCO Position: Q1 2020 in Review
UBS Group sold out of Medicines Co (MDCO) in Q1 2020, closing a stake of 1,277,342 shares — an estimated $108M sold.
UBS Group first reported a position in MDCO in Q4 2014 and held it in 21 quarters. The position peaked at $108M in Q4 2019. 1 fund tracked by Wall St. Rank holds MDCO as of Q1 2020.
- UBS Group reported no remaining Medicines Co position as of Q1 2020 after selling out during the quarter.
- UBS Group sold 1,277,342 Medicines Co shares in Q1 2020, an estimated $108M.
- UBS Group first reported a position in Medicines Co in Q4 2014 and held it in 21 quarters.
- UBS Group's Medicines Co position peaked at $108M in Q4 2019.
- 1 fund tracked by Wall St. Rank held Medicines Co as of Q1 2020.
Based on UBS Group's 13F filing for Q1 2020, filed 1 May 2020.